AI-assisted international press reviewPress review

Sumitomo Chemical Develops Innovative Alumina to Enhance Ceramic Separation Membranes

Sumitomo Chemical has developed a high-performance alumina technology that improves the permeability of ceramic separation membranes while maintaining their efficiency. This breakthrough, resulting from joint research with Kobe University, could transform wastewater treatment and other industrial applications by reducing contaminant adhesion and increasing filtration flow rates. The results promise more efficient membranes for various sectors, including food processing and biotechnology.

Le Mars Impact Fund Invests Over $13 Million to Strengthen Agricultural Communities

The Le Mars Impact Fund announces strategic grants aimed at enhancing the resilience of agricultural communities, developing youth skills, and promoting animal welfare. These investments, spread across Côte d'Ivoire, India, the United States, and Thailand, aim to support cocoa and mint farmers while combating rabies and strengthening children's education in rural areas.

AstraZeneca Finalizes Licensing Agreement for Lung Cancer Treatment Zegfrovy

AstraZeneca has announced the finalization of an exclusive licensing agreement for Zegfrovy, an EGFR inhibitor aimed at enhancing treatment options for lung cancer patients. This drug, already approved in China, is set to launch in the United States by the end of 2026, with an initial investment of $600 million for its development. Zegfrovy specifically targets exon 20 insertion mutations of the EGFR, a condition that presents an urgent need for new therapies.

Tagrisso and Orpathys: Significant Advances in Lung Cancer Treatment

Results from the Phase III SANOVO trial in China show that the combination of Tagrisso and Orpathys significantly improves progression-free survival in patients with non-small cell lung cancer (NSCLC) harboring EGFR mutations and MET overexpression, reinforcing Tagrisso's role as a foundational treatment. These findings are part of a series of clinical trials aimed at transforming therapeutic approaches for this patient population.

Enhertu and Pertuzumab Supply: Major Advancement for HER2-Positive Breast Cancer

The EU's approval of Enhertu in combination with pertuzumab marks a significant advancement in the treatment of HER2-positive metastatic breast cancer, offering a median progression-free survival of over three years, according to results from the DESTINY-Breast09 trial. This new therapeutic option could transform care standards for patients, addressing an urgent need for improved clinical outcomes in this aggressive disease.

Classico Unifies Traditions with New Football Sauce for NFL 2026

As the kickoff for NFL 2026 approaches, Classico unveils a limited-edition pasta sauce that merges Sunday football rituals with family meals, providing a convenient and delicious culinary experience for fans. Available exclusively on Walmart.com starting September 8, this sauce promises to transform game day meals into a delightful tradition.

HOCHTIEF Strengthens Its Position in Energy Infrastructure with Autmatec Acquisition

The acquisition of Autmatec by HOCHTIEF marks a key milestone in its expansion strategy in the energy infrastructure market, integrating essential skills to modernize electricity transmission networks in Europe. This move, set against a backdrop of massive investments in infrastructure, will enable HOCHTIEF to better meet the growing demands for electrification and the integration of renewable energies.

Iberdrola Unveils Immersive Exhibition on the Evolution of Electricity

Iberdrola's exhibition "An Electrifying Journey," open for free in Madrid, explores the history and future of electricity through interactive and educational experiences. The initiative aims to inspire younger generations to pursue technology careers related to electricity and is part of the celebrations for the company's 125th anniversary.

Novartis Reports Promising Results for Remibrutinib in Multiple Sclerosis

Phase III clinical trials REMODEL-1/-2 demonstrate that remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, significantly reduces relapse rates in patients with relapsing multiple sclerosis while showing a favorable safety profile. Novartis plans to submit these results to health authorities for global approval and to present them at the MSToronto2026 congress.

GSK Advances mRNA Flu Vaccine to Phase III After Promising Phase II Results

GSK has announced encouraging results for its mRNA flu vaccine candidate, demonstrating immune responses superior to traditional vaccines. A Phase III trial is scheduled for September 2026, aiming to target key antigens of the influenza virus, with hopes of improving protection against this seasonal illness that affects millions each year.

Johnson & Johnson Announces Conference Call for Q3 2026 Results

On October 13, 2026, Johnson & Johnson will host a conference call to discuss its third-quarter financial results, led by its CEO and other executives. Investors will be able to access the call by phone or through the company's website, with a replay available after the event.

Recognition of Projects for Excellence in Safety and Innovation

The Camp Phoenix project in Indonesia has been praised for its excellence in safety, while the Gunyama Park Aquatic and Recreation Centre in Sydney showcases the alliance between innovative engineering and sustainable design. Other initiatives, such as Leighton Asia's graduate program, highlight the importance of digital innovation in training future engineers. CIMIC Group and Sedgman continue to play a key role in large-scale projects, thereby strengthening their market position.

VINCI Launches €250 Million Share Buyback Program

As part of its share buyback program, VINCI has entered into an agreement with an investment service provider to acquire shares worth up to €250 million, with specific conditions regarding the purchase price, in accordance with the decisions made by the shareholders' general meeting.

Enel Launches Institutional Campaign Highlighting Energy Across Generations

Enel's new campaign, launched on August 30, 2026, illustrates the journey of a couple and the evolution of Italy, while emphasizing the essential role of energy in daily life. With the slogan "Enel. Energy for Generations," the campaign showcases the company's legacy and innovation, accompanied by the famous song "A Whiter Shade of Pale" to evoke continuity and trust between Enel and local communities.

Untitled

Terres Inovia and UniLaSalle Strengthen Their Partnership in Agritech Training

The partnership between Terres Inovia and UniLaSalle, initiated in June 2025, is being reinforced with an increase in interventions focused on agroecology and agricultural machinery, aimed at enhancing the skills of sector stakeholders. Experts from the technical institute are leading continuing education modules, thereby broadening the dissemination of technical recommendations and elevating the quality of the teachings provided.

Claas Invests €9 Million in Climate Testing Facility Near Le Mans

Agricultural machinery manufacturer Claas has announced a €9 million investment to build a climate testing facility in Trangé, aimed at enhancing the research and development of its tractors. This project reflects a commitment to innovation and adaptation to extreme weather conditions, while also supporting local employment with a factory that produces 10,000 tractors annually.

Agricultural Robotics Becomes More Attractive to Investors

Advancements in robotics and AI are transforming the agricultural landscape, making machines more flexible and reliable. Reservoir VC has announced a $50 million fund to support startups in the sector, emphasizing the importance of systemic support to overcome harvesting challenges. Machines are now assembled and tested in less than six months, paving the way for rapid and efficient industrialization.

Lidea Launches Seed Coating to Reduce Nitrogen Inputs

European seed company Lidea has introduced Nitro Boost, a seed coating developed in collaboration with Agronutrition by DSG that combines biofertilization and biostimulation. Targeted primarily at corn and cereals, this solution integrates bacteria capable of fixing atmospheric nitrogen, a biostimulant, and a zinc and manganese complex. According to the seed company, it could reduce mineral fertilizer applications by 20 to 40 nitrogen units per hectare. Over 33 trial sites from 2022 to 2025, Lidea reports yield gains of up to 4.1 q/ha under water stress conditions.

Kraft Heinz to Present Business Strategy at Barclays Global Consumer Conference 2026

Kraft Heinz, a global leader in food production, will announce its business strategy at the Barclays Global Consumer Conference in September 2026. A live webcast will be available, followed by a replay accessible for six months. With a revenue of $25 billion in 2025, the company continues to invest in its iconic brands to meet consumer expectations.